Active · per the CBE, 29 October 2026

IMPACTHEO

BE0859775138

Rechtspersoon Public limited company 1 establishment

Franklin Rooseveltlaan 50, 1050 Brussel

Active for

23 year, 3 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Busy address KBO

    107 other companies have their registered office at the same address; threshold 10.

  • Not on Peppol Peppol

    Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

IMPACTHEO from Brussel, company number BE0859775138, closed financial year 2025 with a result of € -306,892 after tax. For that financial year IMPACTHEO recorded a gross margin of € -156,963 and equity of € 8.5 million. Compared with financial year 2024, the result moved from € 885,119 to € -306,892. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 23, 2026.

What it is worth Healthy

€ 8.5 million

▼ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -306,892

▼ still € 885,119 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 298,281

▼ 93% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 665,841.

People and assets in 2025

Full-time equivalents

0.8

▼ 0.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 28,649

▼ 59% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 17,895

▼ 76% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 4,993

▼ 62% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € -335,981 € -395,102 € -353,187 € -156,963 ▲ € 196,225
Profit after taxes € -421,041 € -1,004,033 € 885,119 € -306,892 ▼ € 1.2 million
Equity € 8,895,647 € 7,891,614 € 8,776,733 € 8,469,841 ▼ 3%
Total debts € 6,409,445 € 6,473,733 € 6,567,119 € 6,618,933 ▲ 1%
Cash € 5,260,529 € 1,762,759 € 4,031,565 € 298,281 ▼ 93%
Retained profit € 1,091,647 € 87,614 € 972,733 € 665,841 ▼ 32%
Balance sheet total € 15,305,092 € 14,365,347 € 15,343,853 € 15,088,774 ▼ 2%
Employees (FTE) 0.6 1 1 0.8 ▼ 0.2

Key figures of IMPACTHEO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to IMPACTHEO?

What happened at IMPACTHEO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Frédéric Debaste stepped down as director. NBB
  • Benoit Daenen stepped down as director. NBB
  • Bernard De Cannière stepped down as director. NBB
  • Annemie Schaus stepped down as director. NBB
  • Françoise Magerman stepped down as director. NBB
  • Daniele Carati stepped down as director. NBB
  • New annual accounts for financial year 2025: loss of € 306,892 (▼ € 1.2 million vs 2024). filed late Source: NBB ↗
  • Grégory Miller stepped down as director. NBB

In short

From € 421,041 loss in 2022 to € 306,892 loss in 2025.

Paid € 187,348 in corporate taxes since 2022.

Best year ever: 2024, with € 885,119 profit.

Management

The shares are held by Université Libre de Bruxelles (99%). It owns 60% of Theodiris, 39.8% of Diginnov, 32.8% of Brussels South Charleroi BioPark Dev, 30% of Slow Surg, 30% of 3D Fibroscreen and 30% of Aetech Medical itself.

Directors

According to the 2025 annual accounts

Frédéric Debaste

Director

since 2025 · until 2031

Annemie Schaus

Director

since 2020 · until 2027

Grégory Miller

Director

Also active at: 50°NORTH VENTURES, BbyD

since 2023 · until 2025

Bernard De Cannière

Chairman of the board

since 2024 · until 2030

Françoise Magerman

Director

Also active at: BIOPOLE ULB - CHARLEROI en abrégé BUC

since 2020 · until 2027

since 2020 · until 2025

Benoit Daenen

Director

since 2025 · until 2031

since 2020 · until 2027

Establishments

Establishment units

Physical locations of this company

Registered office

Franklin Rooseveltlaan 50

1050 Brussel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0859.775.138
VAT number
BE 0859.775.138
Registered office
Franklin Rooseveltlaan 50, 1050 Brussel
Names & denominations
IMPACTHEO
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
25 July 2003
Peppol
Not registered

Frequently asked questions

What is the address of IMPACTHEO?
The registered office of IMPACTHEO is located at Franklin Rooseveltlaan 50, 1050 Brussel.
Is IMPACTHEO still active?
Yes. According to the CBE (29 October 2026) IMPACTHEO is active, legal situation “Normale toestand”, started on 25 July 2003.
Is IMPACTHEO registered on Peppol?
No, IMPACTHEO is currently not registered on the Peppol network.
What is the enterprise number of IMPACTHEO?
The enterprise number of IMPACTHEO is BE0859775138.
When was IMPACTHEO founded?
IMPACTHEO was founded on 25 July 2003.
Who owns IMPACTHEO?
The shares are held by Université Libre de Bruxelles (99%). It owns 60% of Theodiris, 39.8% of Diginnov, 32.8% of Brussels South Charleroi BioPark Dev, 30% of Slow Surg, 30% of 3D Fibroscreen and 30% of Aetech Medical itself.